Digest Network How does it work
Network
/
Society
C₂
Not verified

C₂N Diagnostics, LLC

What we write about

BiotechnologyHealthIndustriaMedicine - variousScienza

16 Press releases

View all press releases
13/11/2025
Psychiatry
Health
Scienza
Eventi
C2N Diagnostics and WashU Medicine Teams Receive Prestigious Award from Human Proteome Organization
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
25/09/2025
Industria
Sanità
Third age
Medicine - various
Scienza
Biotechnology
Windows / Shopping
Health
New Research Reinforces C2N’s PrecivityAD2™ Blood Test as a Highly Accurate Tool to Detect Brain Amyloid Pathology in Symptomatic Patients
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
03/09/2025
Dynamic Growth Leads C2N Diagnostics to Expand St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
25/08/2025
Sanità
Windows / Shopping
Medicine - various
Biotechnology
Third age
Health
Industria
C2N Diagnostics Expands the PrecivityAD2™ Alzheimer’s Disease Blood Test Intended Use to Patients 50 Years and Older
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
07/08/2025
Scienza
Psychiatry
Medicine - various
Biotechnology
Sanità
Pharmaceuticals
Health
Labour market
Industria
C2N Announces Major Global Expansion, Adds Six New International Partners
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
15/07/2025
Psychiatry
Scienza
Medicine - various
Biotechnology
Health
Pharmaceuticals
Sanità
Industria
C2N Diagnostics Expands Portfolio of Blood Tests for Clinical Researchers Studying Alzheimer’s Disease and Related Dementias
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
13/03/2025
Labour market
Medical and health
Health
Sanità
Biotechnology
Samsung Invests in C2N Diagnostics
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
24/02/2025
Biotechnology
Medical and health
Sanità
Health
Medicine - various
Industria
C2N Diagnostics’ PrecivityAD2™ Blood Test Receives MHRA Medical Device Certification in the United Kingdom
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
31/01/2025
Scienza
Biotechnology
Sanità
Health
Psychiatry
Medicine - various
Market analysis
Industria
Study Highlights How C2N’s PrecivityAD2™ Blood Biomarker Test Use Improves Clinical Decision-Making in the Evaluation for Alzheimer’s Disease
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
28/01/2025
Scienza
Biotechnology
Medical and health
Health
Psychiatry
Industria
First Canadian Clinic to Offer C2N’s PrecivityAD2™ Blood Test to Help Healthcare Providers Diagnose Alzheimer’s Disease, Joining Global Community in Embracing Breakthrough Technology
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0